Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries.

Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, Schechter M, Laurent C, Keiser O, May M, Sprinz E, Egger M, Anglaret X; ART-LINC, IeDEA..

Bull World Health Organ. 2008 Jul;86(7):559-67.

2.

The impact of gender and income on survival and retention in a South African antiretroviral therapy programme.

Cornell M, Myer L, Kaplan R, Bekker LG, Wood R.

Trop Med Int Health. 2009 Jul;14(7):722-31. doi: 10.1111/j.1365-3156.2009.02290.x. Epub 2009 Apr 27.

3.

Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean.

Carriquiry G, Fink V, Koethe JR, Giganti MJ, Jayathilake K, Blevins M, Cahn P, Grinsztejn B, Wolff M, Pape JW, Padgett D, Madero JS, Gotuzzo E, McGowan CC, Shepherd BE.

J Int AIDS Soc. 2015 Jul 10;18:20016. doi: 10.7448/IAS.18.1.20016. eCollection 2015.

4.

Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.

Pujades-Rodríguez M, Balkan S, Arnould L, Brinkhof MA, Calmy A; AIDS Working Group of MSF..

JAMA. 2010 Jul 21;304(3):303-12. doi: 10.1001/jama.2010.980.

PMID:
20639564
5.

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P, Wood R, Laurent C, Sprinz E, Seyler C, Bangsberg DR, Balestre E, Sterne JA, May M, Egger M; Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration.; ART Cohort Collaboration (ART-CC) groups..

Lancet. 2006 Mar 11;367(9513):817-24. Erratum in: Lancet. 2006 Jun 10;367(9526):1902.

PMID:
16530575
6.

Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.

Nash D, Katyal M, Brinkhof MW, Keiser O, May M, Hughes R, Dabis F, Wood R, Sprinz E, Schechter M, Egger M; ART-LINC Collaboration of IeDEA..

AIDS. 2008 Nov 12;22(17):2291-302. doi: 10.1097/QAD.0b013e3283121ca9.

7.

The social and clinical characteristics of patients on antiretroviral therapy who are 'lost to follow-up' in KwaZulu-Natal, South Africa: a prospective study.

Peltzer K, Ramlagan S, Khan MS, Gaede B.

SAHARA J. 2011;8(4):179-86. doi: 10.1080/17290376.2011.9725002.

PMID:
23236959
8.

Electronic medical record systems, data quality and loss to follow-up: survey of antiretroviral therapy programmes in resource-limited settings.

Forster M, Bailey C, Brinkhof MW, Graber C, Boulle A, Spohr M, Balestre E, May M, Keiser O, Jahn A, Egger M; ART-LINC collaboration of International Epidemiological Databases to Evaluate AIDS..

Bull World Health Organ. 2008 Dec;86(12):939-47.

9.

Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.

May M, Boulle A, Phiri S, Messou E, Myer L, Wood R, Keiser O, Sterne JA, Dabis F, Egger M; IeDEA Southern Africa and West Africa..

Lancet. 2010 Aug 7;376(9739):449-57. doi: 10.1016/S0140-6736(10)60666-6. Epub 2010 Jul 15.

10.

Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.

ART-LINC of IeDEA Study Group., Keiser O, Tweya H, Boulle A, Braitstein P, Schecter M, Brinkhof MW, Dabis F, Tuboi S, Sprinz E, Pujades-Rodriguez M, Calmy A, Kumarasamy N, Nash D, Jahn A, MacPhail P, Lüthy R, Wood R, Egger M.

AIDS. 2009 Sep 10;23(14):1867-74. doi: 10.1097/QAD.0b013e32832e05b2.

11.

Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.

Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, Mtonga V, Reid S, Cantrell RA, Bulterys M, Saag MS, Marlink RG, Mwinga A, Ellerbrock TV, Sinkala M.

JAMA. 2006 Aug 16;296(7):782-93.

PMID:
16905784
12.

Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration.

Leroy V, Malateste K, Rabie H, Lumbiganon P, Ayaya S, Dicko F, Davies MA, Kariminia A, Wools-Kaloustian K, Aka E, Phiri S, Aurpibul L, Yiannoutsos C, Signaté-Sy H, Mofenson L, Dabis F; International IeDEA Pediatric Working Group1..

J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):208-19. doi: 10.1097/QAI.0b013e31827b70bf.

13.

Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study.

Cornell M, Johnson LF, Schomaker M, Tanser F, Maskew M, Wood R, Prozesky H, Giddy J, Stinson K, Egger M, Boulle A, Myer L; International Epidemiologic Databases to Evaluate AIDS-Southern Africa Collaboration..

Lancet HIV. 2015 Sep;2(9):e368-75. doi: 10.1016/S2352-3018(15)00113-7. Epub 2015 Aug 4.

14.

Effect of baseline CD4 cell count at linkage to HIV care and at initiation of antiretroviral therapy on mortality in HIV-positive adult patients in Rwanda: a nationwide cohort study.

Nsanzimana S, Remera E, Kanters S, Forrest JI, Ford N, Condo J, Binagwaho A, Bucher H, Thorlund K, Vitoria M, Mills EJ.

Lancet HIV. 2015 Sep;2(9):e376-84. doi: 10.1016/S2352-3018(15)00112-5. Epub 2015 Aug 4. Erratum in: Lancet HIV. 2015 Sep;2(9):e364.

PMID:
26423551
15.

Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration.

Tuboi SH, Brinkhof MW, Egger M, Stone RA, Braitstein P, Nash D, Sprinz E, Dabis F, Harrison LH, Schechter M.

J Acquir Immune Defic Syndr. 2007 May 1;45(1):52-9.

PMID:
17460471
16.

Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America.

ART-LINC Collaboration of International Databases to Evaluate AIDS (IeDEA)., Keiser O, Anastos K, Schechter M, Balestre E, Myer L, Boulle A, Bangsberg D, Touré H, Braitstein P, Sprinz E, Nash D, Hosseinipour M, Dabis F, May M, Brinkhof MW, Egger M.

Trop Med Int Health. 2008 Jul;13(7):870-9. doi: 10.1111/j.1365-3156.2008.02078.x. Epub 2008 Mar 27.

17.

Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa.

Fox MP, Sanne IM, Conradie F, Zeinecker J, Orrell C, Ive P, Rassool M, Dehlinger M, van der Horst C, McIntyre J, Wood R.

AIDS. 2010 Aug 24;24(13):2041-50. doi: 10.1097/QAD.0b013e32833c703e.

18.

Loss to follow-up in a community clinic in South Africa--roles of gender, pregnancy and CD4 count.

Wang B, Losina E, Stark R, Munro A, Walensky RP, Wilke M, Martin D, Lu Z, Freedberg KA, Wood R.

S Afr Med J. 2011 Apr;101(4):253-7.

19.

Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa.

Ekouevi DK, Balestre E, Ba-Gomis FO, Eholie SP, Maiga M, Amani-Bosse C, Minga A, Messou E, Sow PS, Lewden C, Traoré HA, Bissagnene E, Dabis F; IeDEA West Africa Collaboration..

Trop Med Int Health. 2010 Jun;15 Suppl 1:34-42. doi: 10.1111/j.1365-3156.2010.02505.x.

20.

Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.

Bedell R, Heath KV, Hogg RS, Wood E, Press N, Yip B, O'Shaughnessy MV, Montaner JS.

Antivir Ther. 2003 Oct;8(5):379-84.

PMID:
14640384

Supplemental Content

Support Center